Coronary bypass surgery, also known as coronary artery bypass grafting (CABG), is a medical procedure designed to improve blood flow to the heart muscle when coronary arteries become narrowed or blocked. This condition, often caused by a buildup of fatty deposits (atherosclerosis), can lead to reduced blood supply to the heart, resulting in chest pain (angina) or even a heart attack. During a coronary bypass, a surgeon grafts blood vessels, typically taken from the patient's leg or chest, to bypass the blocked arteries, creating new pathways for blood to reach the heart muscle. This surgical intervention aims to restore proper blood flow, alleviate symptoms, and enhance overall heart function. Coronary bypass is often recommended when other treatments, such as medication or lifestyle changes, prove insufficient in managing coronary artery disease. While it is a major surgical procedure, advancements in medical technology and surgical techniques have significantly improved the safety and success rates of coronary bypass surgeries, making it a crucial option for individuals with advanced coronary artery disease.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India